Treating Multiple Myeloma by Targeting the NF-Kappa-B Pathway with Gadd45-Beta/MKK7 Inhibitors

Lynn Goldin

Autoimmune Diseases and Risk for Lymphoma and Other Cancers

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Robert Hoover

Nordic Countries Linked Medical Birth and Cancer Registries Project

Multiple myeloma and immunoproliferative diseases Breast

Conor C Lynch

Specific skeletal targeting of MMP-2 for the treatment of multiple myeloma

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Kenneth C Anderson

Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Nathaniel Rothman

Studies in the Janus Cohort

Trachea, bronchus and lung Thyroid Testis Prostate Pancreas Ovary Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Lip, oral cavity Leukaemia

Pathology

Nikhil C Munshi

Genomics Core

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Nikhil C Munshi

Clinical and Tissue Core

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Laura B Freeman

Pooling project of NCI and Cross-Canada studies

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Sarah A Holstein

Rab Geranylgeranylation: a Novel Therapeutic Target in Multiple Myeloma

Multiple myeloma and immunoproliferative diseases